Company / CompetitorEnterpriseEnriched

23andMe

23andMe is a consumer genetics and research company offering direct-to-consumer DNA testing for ancestry insights and health-related genetic reports. It combines large-scale genotyping, statistical genetics, and digital engagement to generate a unique database of consented genetic and phenotypic information. The company also leverages this data to drive therapeutics discovery and partnerships in biopharma and precision medicine.

📍 Sunnyvale, California, United StatesFounded 2006MixedWebsite →

Primary Focus

Consumer genetic testingGenomics and bioinformaticsDigital health and wellnessBiopharmaceutical research and drug discoveryAncestry and genealogy services

Company Info

Public

Employees: 1,000–2,000

Social

Use Cases Mentioning 23andMe

healthcareClassical-Supervised

Genetics, Epigenetics, and Microbiome Analysis for Drug Response and Disease Mechanisms

Think of every patient as a unique garden: their genes are the soil, epigenetics is how the soil has been treated over time (fertilizer, pollution, stress), and the microbiome is the mix of plants and microbes living there. This work is about using data and models to understand how all three together affect health and how people respond to medicines, so treatments can be tailored to each person’s “garden” instead of using one-size-fits-all drugs.

23andMe

Primary Focus

Company Info

Social

Active Industries

AI Patterns

Tech Stack

Also Competes With

Use Cases Mentioning 23andMe

Genetics, Epigenetics, and Microbiome Analysis for Drug Response and Disease Mechanisms